Streptococcus Pneumoniae anticorps

N° du produit ABIN110942

L’anticorps anti-Streptococcus Pneumoniae Monoclonal Souris est utilisé pour la détection de Streptococcus Pneumoniae dans des échantillons de Streptococcus pneumoniae. Il a été validé pour IF et EIA.

Aperçu rapide pour Streptococcus Pneumoniae anticorps (ABIN110942)

Antigène: Streptococcus Pneumoniae

Reactivité: Streptococcus pneumoniae

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp Streptococcus Pneumoniae est non-conjugé

Application: Immunofluorescence (IF), Enzyme Immunoassay (EIA)

Clone: 128-390

Détail du produit anti-Streptococcus Pneumoniae anticorps

Purification: Affinity Chromatography on Protein A.

Immunogène: Native S. pneumoniae (NCTC 10319).

Isotype: IgG1

Information d'application

Indications d'application: ELISA. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Concentration: 1.0 mg/mL

Buffer: PBS, pH 7.2 containing 0.09 % Sodium Azide as preservative.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur Streptococcus Pneumoniae

Antigène: Streptococcus Pneumoniae

Classe de substances: Bacteria

Sujet: Bronchial pneumonia is most prevalant in infants, young children and aged adults. It is caused by various bacteria, including Streptococcus pneumoniae. Streptococcus pneumoniae are Gram positive, lancet shaped cocci (elongated cocci with a slightly pointed outer curvature). Usually they are seen as pairs of cocci (diplococci), but they may also occur singly and in short chains. S. pneumoniae is a transient member of the normal flora, colonizing the nasopharynx of 40 % of healthy adults and children with no adverse effects. There are more than 90 serotypes: serotypes 6, 14, 18, 19, and 23 are the most prevalent accounting for 60-80 % of infections depending on the area of the world. Pneumococcal infection accounts for more deaths than any other vaccine preventable bacterial disease.